A Study of Multiple Doses of ALXN2050 in Healthy Adults
Clinical trial NCT05047484 · COMPLETED
Trial details
- NCT number
- NCT05047484
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-07-23
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.